Abstract
The human DEAD-box protein 3 (DDX3) has been reported as a positive regulator and functions in the induction of type I interferon signaling. We elucidated the function of DDX3 in the positive regulation of IFNB production in non-pDC cells. We found that DDX3 regulates virus-induced activation of IFNB at the level of IRF-3. However, it does not affect conventional innate signaling, including IRF-3 phosphorylation, dimerization, or nuclear translocation of IRF-3, but has some downstream events after IRF-3 phosphorylation. Co-immunoprecipitation analyses revealed that DDX3 interacts with IRF-3 through its DNA-binding domain and promotes IRF-3-mediated IFNB promoter activation. DDX3 does not affect the formation of the IRF-3/p300/CBP complex. Instead, ChIP and EMSA assay revealed that DDX3 promotes the recruitment of IRF-3 and transcriptional co-activator p300/CBP to the IFNB promoter. The ATP binding pocket of DDX3 is involved in this association and is essential for the transcriptional activation. Taken together, our study demonstrates that DDX3 plays an important role in guiding a transcription factor complex formed by antiviral signaling to the target gene promoter.
Similar content being viewed by others
Introduction
Innate immunity is the first line of defense against invading pathogens. Host cells recognize the pathogen-associated molecular patterns (PAMPs) by pathogen recognition receptors (PRRs), including Toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), and intracellular DNA sensors, and initiate antiviral responses1. Viral double-stranded RNA (dsRNA) or bacterial lipopolysaccharide (LPS) in the endosome is recognized by TLR3 or TLR4, respectively, whereas cytoplasmic viral dsRNA is sensed by RIG-I, MDA5, or protein kinase R (PKR)2,3,4,5.
Upon sensing cytoplasmic viral RNAs, N-terminal caspase activation and recruitment domain (CARD) of RIG-I and MDA5 interact with mitochondrial signaling adapter (MAVS), which subsequently recruit the downstream proteins kinases TBK1 or IKKε, which then phosphorylate and activate IRF-36. IRF-3 is the most important factor in the regulation of virus-induced interferon (IFN) gene activation. IRF-3 is usually found in the cytoplasm in an inactive form7. Upon virus infection, IRF-3 is activated to promote antiviral responses. Activation of IRF-3 involves a cascade of events: phosphorylation at Ser 386, homodimer formation, nuclear translocation, and assembly of a complex containing p300/CBP on the regulatory elements of type I IFN promoter to turn on transcription7,8,9,10,11,12. Secreted IFN binds to the IFN receptor and activates the JAK/STAT signaling pathway to induce the expression of interferon-stimulated genes (ISGs), which play an essential role in antiviral activity13,14.
DDX3 is a member of the DEAD (Asp-Glu-Ala-Asp)-box helicase family15,16. DDX3 exists in two isoforms, DDX3X and DDX3Y, located on the X and Y chromosomes, respectively17,18. DDX3X (referred to as DDX3) is ubiquitously expressed in most tissues and cells, whereas the expression of DDX3Y is limited to the male germline19. DDX3X and DDX3Y were reported to have partial redundant functions20. Like most other DEAD-box helicases, DDX3 is a multifunctional protein with functions in RNA metabolism, including RNA transcription, RNA splicing, RNA transport, RNA degradation, and translation21,22.
There have been several reports claiming that DDX3 is involved in virus-induced signaling leading to IFN production. It was reported that DDX3 recognizes viral RNA and associates with MAVS, suggesting that DDX3 itself acts as a viral RNA sensor upstream of MAVS and TBK1/IKKε23. DDX3 was identified as a target of Vaccinia virus immune evading factor K7 and interacts with IKKε to facilitate IRF-3 activation24. Interaction of DDX3 with IKKε results in the phosphorylation of DDX3 and facilitates IRF-3 phosphorylation by IKKε, and DDX3 acts as an essential scaffold for the kinase/substrate complex25. Another report identified DDX3 as an interacting protein of TBK1 and like IKKε, TBK1 phosphorylates DDX326. Although the precise mechanism has not been delineated, it was demonstrated that DDX3 is recruited to the type I IFN promoter by ChIP analysis26. The above results were obtained using non-pDC cells. pDC is a major IFN-α producer that utilizes distinct sensor TLR7/9, and kinases NIK, IKKα, and IRF-7. DDX3 facilitates this pathway to activate IRF-727; however, the biological functions of DDX3 in innate antiviral immunity are not fully understood.
We elucidated the function of DDX3 in the positive regulation of IFN-β production in non-pDC cells. We determined that DDX3 regulates virus-induced activation of type I IFN at the level of IRF-3. However, our study suggests that DDX3 is not involved in the phosphorylation, dimerization, or nuclear translocation of IRF-3, but has some downstream events after IRF-3 phosphorylation. Co-immunoprecipitation analyses demonstrated that DDX3 has intrinsic activity to interact with IRF-3 and promotes IRF-3-mediated IFNB promoter activation. DDX3 interacts with IRF-3 through its DNA-binding domain. However, it does not affect the formation of the IRF-3/p300/CBP complex. Instead, DDX3 promotes the recruitment of IRF-3 and transcriptional co-activator p300/CBP to its target promoter site. In addition, we found that DDX3 promotes IRF-3-mediated IFNB promoter activation and augments IFN-β production in response to viral infection through its interaction with IRF-3.
Results
DDX3 positively regulates the antiviral innate immune responses
Previous studies reported that DDX3 positively regulates RLR signaling to facilitate type I IFN production23,24,25,26,28. As these reports suggested that DDX3 acts as multifunctional adaptor molecule in the RLR signaling pathway, we re-investigated its role in RLR signaling. To further substantiate the biological role of DDX3 in the innate antiviral response, we generated DDX3-deficient 293T and HeLa cells by CRISPR/Cas9 gene editing. Both DDX3-deficient 293T and HeLa cells contain non-functional N-terminally truncated proteins (Supplementary Fig. 1a).
These cells were transfected with 5′-triphosphate double-stranded RNA (5′ppp-dsRNA), a ligand for RIG-I or high molecular weight (HMW) poly (I:C), a ligand for MDA5 or infected with Sendai virus (SeV) or Newcastle disease virus (NDV). As predicted, IFNB expression was significantly induced by these stimuli in wild type (WT) cells (Fig. 1a). In DDX3 KO cells, these responses were markedly attenuated. To rule out the possibility of cell type specificity, we performed the above experiments in HeLa and HeLa DDX3 KO cells, and observed similar results (Supplementary Fig. 1c).
Next, we investigated the induction kinetics of IFNB gene by SeV in WT and DDX3 KO 293T (Fig. 1b) and HeLa cells (Supplementary Fig. 1d). DDX3 was required for efficient SeV-induced IFNB gene expression at all time points (Fig. 1b). Consistent with the attenuated IFN response, SeV RNA levels markedly increased in DDX3 KO 293T (Fig. 1c) and HeLa cells (Supplementary Fig. 1e).
To confirm the increased expression of IFNB mediated by DDX3 and rule out the possibility that attenuated IFNB induction occurred due to off-target effects of DDX3 gRNAs, we stably complemented the KO cells with WT Flag-DDX3. The reconstituted DDX3 expression was confirmed by Western blot analysis (Supplementary Fig. 1b). WT, DDX3 KO, and DDX3 KO/DDX3 293T cells were then infected with SeV (Fig. 1d) or stimulated with 5′ppp-dsRNA (Fig. 1e). IFNB gene expression induced by SeV and 5′ppp-dsRNA was restored to the same level as that in WT cells by complementation of DDX3. Altogether, these data confirm that DDX3 acts as a positive regulator in RLR-induced IFNB gene expression. Again, the complementation was confirmed using HeLa cells (Supplementary Fig. 1f, g).
DDX3 regulates virus-induced signaling at the level of IRF-3
To ascertain the role of DDX3 in IFNB promoter regulation, we used a reporter gene controlled by the promoter region of IFNB (− 125 to + 19, p-125Luc) and that controlled by 8 repeats of the IRF binding site (p-55C1BLuc)29. These reporter genes were efficiently activated by SeV infection in 293T WT cells, but were markedly attenuated in 293T DDX3 KO cells (Fig. 2a, b). HeLa and HeLa DDX3 KO cells observed similar results (Supplementary Fig. 2a, b). These results are consistent with a previous study26 and suggest that DDX3 positively regulates the IFNB gene through IRF binding sites.
To further clarify the signaling steps in which DDX3 participates, we overexpressed a series of constitutive active signaling adaptors that bypass the viral trigger in 293T, 293T DDX3 KO (Fig. 2c, d), HeLa and HeLa DDX3 KO cells (Supplementary Fig. 2c). Overexpression of CARD of RIG-I and MDA5 directly relay signals to MAVS to trigger the downstream signaling2. Ectopic overexpression of MAVS, which results in its strong aggregation on mitochondria, also triggers the downstream signaling30. Transient overexpression of the regulatory protein kinases TBK1 and IKKε, which are responsible for IRF-3 phosphorylation, result in the phosphorylation of IRF-3 on Ser 38631,32, leading to IFNB gene activation. The IRF-3 5D mutant is constitutively phosphorylated IRF-3 on Ser 386 in human cells by an unknown kinase31 and mimics virus-induced IFNB gene induction. Interestingly, these constitutive active regulators activated p-125Luc and p-55C1BLuc reporters in a DDX3-dependent manner. These data suggest that DDX3 positively regulates the activation of IFNB at the level of IRF-3.
DDX3 does not affect conventional innate signaling, including IRF-3 phosphorylation, dimerization, or nuclear translocation
We examined the kinetics of TBK1 phosphorylation, IRF-3 phosphorylation, and IRF-3 homodimer formation (Fig. 3a) in virus-infected 293T and 293T DDX3 KO cells. Upon SeV infection, the total amount of TBK1 did not change; however, phospho TBK1 (S172) was detectable after 6 hpi and persisted thereafter. IRF-3 was detectable at 0 hpi and progressive mobility retardation in SDS gel was observed after 6 hpi, suggesting its phosphorylation at multiple sites. When the blot was probed with phospho-specific antibody (S396), IRF-3 phosphorylation was observed after 6 hpi and further increased thereafter. Native gel analysis revealed that IRF-3 dimer formation correlated with IRF-3 phosphorylation. Importantly, there was no notable difference in the phosphorylation of TBK1, IRF-3, or IRF-3 dimer formation in the presence or absence of DDX3.
Next, we examined IRF-3 nuclear translocation in SeV-infected cells by cell fractionation and immunofluorescence microscopy. Cell fractionation revealed that IRF-3 species with slow gel mobility were selectively translocated into the nucleus, suggesting phosphorylation-specific translocation in both WT and DDX3 KO cells (Fig. 3b). This observation was confirmed by staining with anti IRF-3 antibody (Fig. 3c). Counting of cells revealed that 66.9% and 67.8% of WT and DDX3 KO cells, respectively, exhibited nuclear translocation of IRF-3, suggesting that IRF-3 nuclear translocation is DDX3-independent.
Collectively, our study reveals that DDX3 does not affect the phosphorylation, dimerization, or nuclear translocation of IRF-3, but it may have some downstream effects after the activation of IRF-3.
Physical association between DDX3 and IRF-3 requires the N-terminal DNA binding domain of IRF-3
Next, we examined the physical association of DDX3 with IRF-3. HA-IRF-3 and Flag-DDX3 were expressed in 293T cells, and co-immunoprecipitated. Consistent with previous reports, physical interaction between DDX3 and IRF-3 was confirmed (Fig. 4a). Endogenous interaction between DDX3 and IRF-3 was also confirmed (Fig. 4b). Truncated IRF-3 (58–427), devoid of its DNA-binding domain, did not associate with DDX3, indicating that the interaction intact DNA-binding domain of IRF-3 is required for the interaction.
DDX3 is required for efficient IRF motif binding of the IRF-3 holocomplex
The IRF-3 holocomplex composed of IRF-3 dimer and coactivator p300/CBP specifically binds to the IRF binding motif and p300/CBP is essential for the DNA binding9,33. We examined the IRF motif binding activity of the extract from WT and DDX3 KO (Fig. 5a). Conventional EMSA revealed that WT cell extract from virus-infected cells exhibited DNA/protein complex (IRF-3 holocompex) and the binding was abolished by competition of excess unlabeled probe DNA. However, the IRF-3 holocomplex was barely detectable in the similar extract from DDX3 KO cells. Of note, the holocomplex binding was restored in DDX3 KO cells complemented with the DDX3 expression vector (DDX3KO/DDX3). Moreover, the SeV infection-dependent association between IRF-3 and p300 was independent of DDX3 (Fig. 5b and Supplementary Fig. 3a). The above in vitro results prompted us to examine IRF-3 binding with the IFNB promoter in cells. We performed ChIP assay to detect binding of IRF-3 (Fig. 5c), p300 (Fig. 5d), and DDX3 (Fig. 5e) to the IFNB promoter. IRF-3, p300, and DDX3 associated with the IFNB promoter in SeV-infected WT cells, but the association was at a background level in DDX3 KO cells.
We performed the above experiments in HeLa and HeLa DDX3 KO cells and observed similar results (Supplementary Fig. 3b-d). Together, these results demonstrate that DDX3 contributes to the DNA binding activity of the IRF-3 holocomplex in vitro and in cells.
ATP binding motif of DDX3 was required for efficient IFNB gene activation by virus infection
Previous studies revealed that DDX3 mutant lacking ATPase activity promoted IFN-β induction by TBK1/IKKɛ overexpression24,26. We re-examined WT, DDX3 KO, and DDX3 KO stably expressing DDX3 K230A (KA) 293T cells (Fig. 6a, b) and HeLa cells (Fig. 6c, d) for IFNB gene activation. Unlike WT DDX3, DDX3 KA failed to complement the DDX3 deficiency in IFNB gene activation. Next, we examined the association of DDX3 KA with IRF-3, as shown in Fig. 4 (Fig. 6e). Efficient association of IRF-3 with DDX3 was observed, but not with DDX3 KA.
Discussion
DDX3 has been implicated in carcinogenesis and human DDX3 syndrome; however, the underlying mechanism(s) for its physiological function are largely unknown. There have been several studies on the regulation of antiviral innate immunity by DDX3. Invading and replicating viral RNA is detected by sensor molecules termed RLR. The three members of RLR belong to the DExD/H-box protein superfamily of RNA helicases. Due to structural similarity, it was hypothesized that DDX3 functions in the sensing step of antiviral responses. However, the published reports are not consistent. We re-examined the function of DDX3 in antiviral immunity. Our results confirm that DDX3 positively regulates virus-induced type I IFN production (Figs. 1, 2). We utilized genome editing technology to avoid off-target effects of siRNA-mediated knockdown. We strictly confirmed that the loss of function of DDX3 by genome editing was complemented by ectopic expression of DDX3. Previous reports suggested that DDX3 facilitates the sensing of viral RNA or subsequent signaling steps. Our study, however, demonstrated that all the steps leading to the activation of IFNB gene were comparable in the presence or absence of DDX3 (Figs. 3, 5b), except that the IRF motif-DNA binding activity of the transcriptional factor complex composed of IRF-3 dimer and p300/CBP, was undetectable in the absence of DDX3 (Fig. 5a). Furthermore, chromatin immunoprecipitation demonstrated that IRF-3, p300, and DDX3 are specifically recruited to the IFNB gene promoter in SeV-infected cells, but not in uninfected cells (Fig. 5c–e). This notion is consistent with previous observation26. DDX3 is dispensable for the formation of the complex of IRF-3 dimer and p300/CBP (Fig. 5b). DDX3 has an intrinsic property to physically associate with IRF-3 (Fig. 4). We demonstrated that the DNA binding domain of IRF-3 (Fig. 4a) and ATP binding pocket of DDX3 (Fig. 6e) are involved in this association, and the latter is essential for transcriptional activation (Fig. 6a-d). Previous studies reported that the ATP binding pocket is dispensable for the transactivation24,26. This discrepancy is likely due to the use of reporter gene in contrast to our analysis of endogenous chromosomal IFNB. Although we do not have a precise explanation, the reporter gene strongly responded to the overexpression of DDX3 KA, a phenomenon not observed with chromosomal IFNB (Supplementary Fig. 4). The involvement of ATP hydrolysis by DDX3 in the transcriptional activation remains to be investigated. A similar scenario has also been described; Chao et al. (2016) have demonstrated that DDX3 acts as a transcriptional regulator by upregulating the promoter activity of the p21waf1/cip1 by interacting with the transcription factor Sp1. This study also provided evidence that DDX3 functioned on p21waf1/cip1 promoter through an ATPase-dependent but helicase-independent manner34.
Based on the above, a model for virus-induced activation of type I IFN mediated by DDX3 was constructed (Fig. 7). Upon sensing viral dsRNA by RLR or TLR3, a signal is transmitted to activate TBK1 (or IKKε) (i). TBK1 phosphorylates IRF-3 at Ser 386 to induce its dimerization (ii). Previous studies have shown that DDX3 is directly phosphorylated by TBK1 and IKKε and that this phosphorylation mediates IRF-3 binding25,26 (iii). Dimerized IRF-3 translocates to the nucleus, where it forms a complex with p300 or CBP; however, in the absence of DDX3, this complex has little activity to recognize the target DNA (vi). Phosphorylated DDX3 is recruited to the IRF-3/p300/CBP complex to confer its full binding activity to the IRF motif sequence of the IFNB promoter (v). DDX3 plays an important role in guiding a transcription factor complex formed by antiviral signaling to the target gene promoter.
According to a previous study, DDX3Y increased IFNB gene expression in a similar way to DDX3X. In fibroblasts lacking both TBK1 and IKKε kinases, both DDX3X and DDX3Y increased the activity of a constitutively active IRF-7 mutant suggesting that TBK1/IKKε-mediated phosphorylation may not require the ability of DDX3X/Y to enhance IFN-β production. Furthermore, DDX3X was shown to enhance the activity of an NFκB reporter gene, suggesting its impact on innate immune responses may extend beyond the IRF-3/7 pathway20.
DDX3 belongs to a family of RNA helicases whose predicted function is to unwind dsRNA to ssRNA through ATP hydrolysis. The function of DDX3 revealed in the current study is novel and remotely related to that of RNA helicases. It is tempting to speculate that DDX3 regulates transcription factors other than IRF-3 to aid in their specific recognition of target genes. This may lead to an understanding of the versatile physiological functions of DDX3.
Methods
Cells and viruses
293T (#CRL-3216, ATCC) (female) and HeLa cells (#CCL-2.2, ATCC) (female) were cultured in Dulbecco’s modified Eagle medium (DMEM) (Nacalai Tesque) supplemented with 10% fetal bovine serum and penicillin–streptomycin (100 U/ml and 100 μg/ml, respectively). All cells were cultured in a humidified atmosphere with 5% CO2 at 37 °C.
DDX3 knockout 293T and HeLa cells were generated by transient transfection of the pSpCas9(BB)-2A-GFP (PX458) vector containing guide RNA (sgRNA: sg-DDX3 forward 5′-caccGTGGCAGTGGAAAATGCGCT-3′ sg-DDX3 reverse 5′-aaacAGCGCATTTTCCACTGCCAC-3′). Cells were subjected to sorting by green fluorescent protein expression levels using the SH800 cell sorter (Sony), followed by limiting dilution in 96-well culture plates to obtain single clones. Deletion of the DDX3 gene was examined by genome sequencing and Western blotting. Western blot analysis of DDX3 expression in 293T/HeLa DDX3 KO cells compared with WT cells using an antibody directed against the N- and C-terminus of DDX3 (Supplementary Fig. 1a).
The PCR primers used for genomic DNA are as follows: DDX3 DNA forward; 5′cagtagccgggcagaagtc-3′ and DDX3 DNA reverse 5′-aatacagcgggccgagac-3′.
To complement DDX3 expression in DDX3 KO cells, lentiviral particles were produced by introducing plasmids pCAG-HIVgp, pVSV-G-RSV-ReV, and pCSII-CMV-MCS-IRES2-Bsd, encoding DDX3 or DDX3 KA, into 293T and HeLa cells. Transfection was performed using polyethylenimine (PEI) (Polysciences) for 293T cells and Lipofectamine 2000 (Invitrogen) for HeLa cells in 10-cm dishes. Media were changed at 6 h post-transfection (hpt), and viral supernatants were collected at 48 and 72 hpt and filtered (0.45 µm). Polybrene (10 µg/ml) was added to the filtered supernatants and used to infect cells. The infected cell lines were selected with blasticidin (10 µg/ml). Colonies were picked and examined for the expression of DDX3 by Western blotting.
Virus infection was performed as previously described35.
Construction of the DDX3 and mutant expression plasmids
Expression plasmid of DDX3 was constructed by RT-PCR amplification of cDNAs from 293T cells with primers encoding the Flag tag at its N-terminus. The PCR products were subcloned into pEF-Bos31. pEF-Flag DDX3 K230A was generated by site-directed mutagenesis of pEF-Flag DDX3 using KOD-plus site-directed mutagenesis (Toyobo). pEF-Flag DDX3 K230A mutant was confirmed by sequencing. IRF-3 and IRF-3 (58-427) expression plasmids were described previously7. Reporter constructs p-125Luc and p-55C1BLuc were described previously29.
Cell stimulation by RNA transfection and by transfection of expression vectors
Poly(I:C) and 5′ppp-dsRNA were transfected for 12 h at a concentration of 1 μg/ml using PEI for 293T cells and Lipofectamine 2000 for HeLa cells. For transient protein expression in 293T and HeLa cells, expression plasmids were transfected using PEI and Lipofectamine LTX, respectively.
Reagents and antibodies
HMW Poly (I:C) was purchased from GE Healthcare. Mouse monoclonal anti-Flag M2 (F1804) was purchased from Sigma-Aldrich. Mouse monoclonal anti-β-actin (sc-47778) and goat polyclonal anti-Lamin B (M-20), mouse anti-DDX3 (C4), and mouse monoclonal anti-GAPDH (0411) were purchased from Santa Cruz Biotechnology. Purified rabbit anti-DDX3 (NB200-196) was purchased from Novus Biologicals. Mouse monoclonal anti-HA.11 (901502) and purified mouse anti-IRF-3 antibody (Go-ChIP) were purchased from BioLegend. Rabbit monoclonal anti-TBK1 (ab40676) was purchased from Abcam. Rabbit monoclonal anti-phospho TBK1 (Ser172) (5483), rabbit monoclonal anti-IRF-3 (Ser396) (D6O1M), and rabbit monoclonal anti-p300 (D8Z4E) were purchased from Cell Signaling Technology. Mouse monoclonal anti-IRF-3 (CBX00167) was purchased from Cosmobio.
RNA isolation and real-time qPCR
Total RNA was extracted from cells using TRIzol reagent. cDNA was generated using ReverTra Ace® qPCR RT Master Mix with gDNA Remover (TOYOBO). Real-time qPCR was performed on the Step One plus real-time PCR system (Applied Biosystems) using THUNDERBIRD SYBR qPCR Mix (TOYOBO). Sequences of the primers used in real-time PCR are listed in Supplementary Table 1.
Subcellular fractionation
Cells collected from 6-well plates were suspended in 25 μl of 0.1% NP-40 in PBS (supplemented with protease inhibitors cocktail), and then centrifuged at 4500g for 5 min at 4 °C. The supernatant was collected as the cytoplasmic fraction. Pellets were washed at least 5 times with 500 μl of 0.1% NP-40 in PBS. Nuclear pellets were then lysed with 20 μl of lysis buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl, and 1% NP-40 supplemented with protease inhibitors cocktail), and then sonicated briefly 3 times before centrifugation at 15,000g for 10 min at 4 °C. The supernatant was kept as the nuclear fraction.
Immunoblotting and immunoprecipitation
293T cells were washed with PBS. Cells were lysed with lysis buffer. Cell extracts were centrifuged at 15,000g for 10 min at 4 °C, and supernatants were collected as protein extracts, re-suspended in 2X SDS sample buffer before boiling and electrophoresis.
For immunoprecipitation, protein extracts were incubated with a mixture of 1 μg of antibody overnight at 4 °C and then Dynabeads protein G (Thermo Fisher) was added and incubate for 4 h. The immunocomplexes were washed 3 times in lysis buffer, followed by denaturation in 2X SDS sample buffer. Denatured proteins were resolved by SDS-PAGE. Proteins on the membranes were visualized on the LAS-4000 instrument (Fujifilm) by chemiluminescence.
Native PAGE
To detect IRF-3 dimerization, native PAGE was performed as described previously31,35. Briefly, a 7.5% polyacrylamide gel was pre-run with the running buffer (25 mM Tris–HCl pH 8.4, 192 mM glycine) in the presence or absence of 0.2% sodium deoxycholate (DOC) in the upper (−) and lower (+) chamber buffers, respectively, at 40 mA for 30 min. Protein extracts were mixed with 5X Native PAGE sample buffer (312.5 mM Tris–HCl pH 6.8, 50% glycerol, and 0.01% BPB). The samples were electrophoresed at 26 mA for 30 min at room temperature. Proteins were transferred onto PDVF membranes and detected by immunoblotting.
Immunostaining
293T cells were cultured in 8-well chamber plates (Ibidi) and either left untreated or infected with SeV for 12 h. Cells were fixed with 4% paraformaldehyde (PFA), permeabilized with 0.25% Triton X-100 in PBS, and treated with 1% bovine serum albumin (BSA) in PBST for 30 min at room temperature before incubation with the primary antibody at 4 °C overnight. The secondary antibody was applied and incubated with the samples for 1 h at room temperature. Cells were counterstained with DAPI and then observed under a confocal microscope (TCS-SP8-Leica Microsystems). Nuclear localization of IRF-3 was analyzed with Keyence BZ-X700 microscope and scored with Keyence Analyzer software. More than 500 cells were counted 3 times for each sample.
Luciferase reporter assay
293T cells were seeded in 24-well plates at 1 × 105 cells per well in DMEM medium with 10% FBS overnight, and transfected with RIG-IN, MDA5N, MAVS, TBK1, IKKε, IRF-3 5D expression plasmids (200 ng) and p-125 Luc (200 ng) or p-55C1B Luc (200 ng) together with pRL-TK-Renilla Luc (10 ng). SeV infection was conducted at 24 hpt. At 12 hpi, cells were lysed with passive lysis buffer (Promega), and firefly luciferase and Renilla luciferase activities were measured using a dual-luciferase assay kit (Promega).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (10 µg) and 0.1 pmol of γ32P-labelled ISRE probe were incubated for 20 min at room temperature in 10 µl of binding mixture (20 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 1% NP-40, 5% glycerol, and 0.2 µg of herring sperm DNA). The DNA–protein complexes were resolved by electrophoresis on 4% acrylamide gels in 1X TBE at 160 V for 1 h at room temperature. The oligonucleotide for ISRE probe is: 5′GAGAGGGAAACCGAAACTGAATTAGCTTTCAGTTTCGGTTTCCCTCT-3′ (the ISRE is underlined).
Chromatin immunoprecipitation
293T cells were cultured in 15-cm dishes and either left untreated or infected with SeV for 12 h before fixation with 1% formaldehyde, followed by quenching using 125 mM glycine. Cell extracts were prepared with lysis buffer and then sonicated using a M220 focused-ultrasonicator (Covaris). After sonication, samples were centrifuged to remove insoluble debris, supernatants were collected, and 5% of each sample was used to measure chromatin input. The rest of the sample was diluted in ChIP dilution buffer (20 mM Tris–HCl, pH 7.5, 1 mM EDTA, 0.5 mM EGTA, 500 mM NaCl, 1% Triton-X-100, 0.1% SDS, and 0.1% DOC). Antibodies were conjugated to Dynabeads protein G (Thermo Fisher) by pre-incubation with 0.5% BSA for 6 h. The beads were incubated with lysate at 4 °C for overnight and washed 5 times with washing buffer (50 mM HEPES–KOH pH 7.4, 500 mM LiCl, 1 mM EDTA, 1% NP40, and 0.7% DOC). To elute the DNA, beads were shaken with 100 μl of elution buffer (50 mM Tris–HCl, pH 8, 10 mM EDTA, and 1% SDS) at 65 °C for 20 min. The immune complexes were reverse cross-linked at 65 °C overnight. After treatment with RNase A and proteinase K, DNA was purified by the Monarch PCR & DNA Cleanup Kit (NEW ENGLAND BioLabs). Real-time PCR analyses were performed using the recovered DNA. The primers of the IFNB promoter were: 5′-GAAAGGGAGAAGTGAAAGTGG-3′ (sense), 5′-AAGGCTTCGAAAGGTTGCAG-3′ (anti-sense).
Statistical analysis
Statistical analysis was performed using Prism software (version 9). Two-way analysis of variance (ANOVA) was used for multiple comparison (*P < 0.05, **P < 0.001, ***P < 0.0001, ns, not significant).
Data availability
All data generated and analyzed during the study is included in the published article and Supplementary Information. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820. https://doi.org/10.1016/j.cell.2010.01.022 (2010).
Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730–737. https://doi.org/10.1038/ni1087 (2004).
Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105. https://doi.org/10.1038/nature04734 (2006).
Kawai, T. & Akira, S. Toll-like Receptor and RIG-1-like Receptor Signaling. Ann. N.Y. Acad. Sci. 1143, 1–20. https://doi.org/10.1196/annals.1443.020 (2008).
Nallagatla, S. R. et al. 5′-Triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318, 14555–21458. https://doi.org/10.1126/science.1147347 (2007).
Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 122, 669–682. https://doi.org/10.1016/j.cell.2005.08.012 (2005).
Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087–1095. https://doi.org/10.1093/emboj/17.4.1087 (1998).
Servant, M. J., Grandvaux, N. & Hiscott, J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 64, 985–992. https://doi.org/10.1016/S0006-2952(02)01165-6 (2002).
Suhara, W., Yoneyama, M., Kitabayashi, I. & Fujita, T. Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex. J. Biol. Chem. 277, 22304–22313. https://doi.org/10.1074/jbc.M200192200 (2002).
Ysebrant de Lendonck, L., Martinet, V. & Goriely, S. Interferon regulatory factor 3 in adaptive immune responses. Cell. Mol. Life Sci. 71, 3873–3883. https://doi.org/10.1007/s00018-014-1653-9 (2014).
Weaver, B. K., Kumar, K. P. & Reich, N. C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359–1368. https://doi.org/10.1128/MCB.18.3.1359 (1998).
Wathelet, M. G. et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell. 1, 507–518. https://doi.org/10.1016/s1097-2765(00)80051-9 (1998).
Schindler, C., Levy, D. E. & Decker, T. JAK-STAT signaling: From interferons to cytokines. J. Biol. Chem. 282, 20059–20063. https://doi.org/10.1074/jbc.R700016200 (2007).
Darnell, J., Kerr, I. & Stark, G. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421. https://doi.org/10.1126/science.8197455 (1994).
Jankowsky, E. RNA helicases at work: Binding and rearranging. Trends Biochem. Sci. 36, 19–29. https://doi.org/10.1016/j.tibs.2010.07.008 (2011).
Cordin, O., Banroques, J., Tanner, N. K. & Linder, P. The DEAD-box protein family of RNA helicases. Gene 367, 17–37. https://doi.org/10.1016/j.gene.2005.10.019 (2006).
Park, S. H., Lee, S. G., Kim, Y. & Song, K. Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3→p11.23. Cytogenet. Cell Genet. 81, 178–179. https://doi.org/10.1159/000015022 (1998).
Lahn, B. T. Functional coherence of the human Y chromosome. Science 278, 675–680. https://doi.org/10.1126/science.278.5338.675 (1997).
Ditton, H. J. The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control. Hum. Mol. Genet. 13, 2333–2341. https://doi.org/10.1093/hmg/ddh240 (2004).
Szappanos, D. et al. The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunity. Plos Pathog. 14, e1007397. https://doi.org/10.1371/journal.ppat.1007397 (2018).
Fuller-Pace, F. V. DExD/H box RNA helicases: Multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 34, 4206–4215. https://doi.org/10.1093/nar/gkl460 (2003).
Linder, P. & Jankowsky, E. From unwinding to clamping-the DEAD box RNA helicase family. Nat. Rev. Mol. Cell Biol. 12, 505–516. https://doi.org/10.1038/nrm3154 (2011).
Oshiumi, H., Sakai, K., Matsumoto, M. & Seya, T. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-β-inducing potential. Eur. J. Immunol. 40, 940–948. https://doi.org/10.1002/eji.200940203 (2010).
Schröder, M., Baran, M. & Bowie, A. G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKɛ-mediated IRF activation. EMBO J. 27, 2147–2157. https://doi.org/10.1038/emboj.2008.143 (2008).
Gu, L., Fullam, A., Brennan, R. & Schroder, M. Human DEAD box helicase 3 couples I B kinase to interferon regulatory factor 3 activation. Mol. Cell. Biol. 33, 2004–2015. https://doi.org/10.1128/MCB.01603-12 (2013).
Soulat, D. et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27, 2135–2146. https://doi.org/10.1038/emboj.2008.126 (2008).
Fullam, A., Gu, L., Höhn, Y. & Schröder, M. DDX3 directly facilitates IKKα activation and regulates downstream signalling pathways. Biochem. J. 475, 3595–3607. https://doi.org/10.1042/BCJ20180163 (2018).
Fullam, A. & Schröder, M. DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication. Biochim. Biophys. Acta. 1829, 854–865. https://doi.org/10.1016/j.bbagrm.2013.03.012 (2013).
Yoneyama, M. et al. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120, 160–169. https://doi.org/10.1093/oxfordjournals.jbchem.a021379 (1996).
Hou, F. et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448–461. https://doi.org/10.1016/j.cell.2011.06.041 (2011).
Mori, M. et al. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279, 9698–9702. https://doi.org/10.1074/jbc.M310616200 (2004).
Takahasi, K. et al. Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change. Genes Cells 15, 901–910. https://doi.org/10.1111/j.1365-2443.2010.01427.x (2010).
Suhara, W. et al. Analyses of Virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300. J. Biochem. 128, 301–307. https://doi.org/10.1093/oxfordjournals.jbchem.a022753 (2000).
Chao, C. H. et al. DDX3, a DEAD Box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21 waf1/cip1 Promoter, is a candidate tumor suppressor. Cancer Res. 66, 6579–6588. https://doi.org/10.1158/0008-5472.CAN-05-2415 (2006).
Abe, H. et al. Priming phosphorylation of TANK-binding kinase 1 by IκB kinase β is essential in toll-like receptor 3/4 signaling. Mol. Cell. Biol. 40, e00509-e515. https://doi.org/10.1128/MCB.00509-19 (2020).
Acknowledgements
This study was supported by research grants from the Japan Agency for Medical Research and Development (Research Program on Emerging and Re-emerging Infectious Diseases [jp19fk0108081h1001 and jp20fk0108081h1202]) and from the Japan Society for the Promotion of Science, Fund for the Promotion of Joint International Research, Fostering Joint International Research “B” [18KK0232], and a Grant-in-Aid for Scientific Research “B” [18H02344].
Author information
Authors and Affiliations
Contributions
W.S. performed the experiments, analyzed the data, and wrote the initial manuscript. L.A.Y.P., H.A., D.K., and H.K., assisted in the study design. T.F. conceived the project, assisted in the study design, and wrote the complete manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Saikruang, W., Ang Yan Ping, L., Abe, H. et al. The RNA helicase DDX3 promotes IFNB transcription via enhancing IRF-3/p300 holocomplex binding to the IFNB promoter. Sci Rep 12, 3967 (2022). https://doi.org/10.1038/s41598-022-07876-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-07876-z
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.